# WES Pharma Inc. – FDA Inspection, Dec 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/6e7f00ec-be3e-4dc9-b0b3-70688bdd39f6
Source feed: FDA_Inspections

> FDA inspection 1074942 of WES Pharma Inc., December 13, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074942
- Company Name: WES Pharma Inc.
- Inspection Date: 2018-12-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1290200 - 2025-11-20](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/86fcfabf-984e-4912-bcd9-e4ce9321452c)
- [FDA Inspection 1223324 - 2023-11-21](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/37ef8a8b-4e2f-433a-b55a-1a0aa0bf154b)
- FDA Inspection 1162565 - 2022-02-18
- FDA Inspection 1141774 - 2021-04-28
- FDA Inspection 1114327 - 2019-12-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)

Company: https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
